# Treatment of Chronic Itch in Patients Under Arsenic Exposure With Naloxone

> **NCT03751111** · PHASE1,PHASE2 · COMPLETED · sponsor: **Xiangya Hospital of Central South University** · enrollment: 126 (actual)

## Conditions studied

- Chronic Pruritus

## Interventions

- **DRUG:** Naloxone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03751111
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-13
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-30
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2025-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03751111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03751111, "Treatment of Chronic Itch in Patients Under Arsenic Exposure With Naloxone". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03751111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*